Back to Search
Start Over
ENGOT-ov43/keylynk-001: A phase III, placebo- and active-controlled trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of advanced BRCA-nonmutated epithelial ovarian cancer
- Source :
- Gynecologic Oncology. 159:89-90
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
- Subjects :
- Oncology
Obstetrics and Gynecology
Subjects
Details
- ISSN :
- 00908258
- Volume :
- 159
- Database :
- OpenAIRE
- Journal :
- Gynecologic Oncology
- Accession number :
- edsair.doi...........b89fcaeb965968eaa8135918672cd2a6
- Full Text :
- https://doi.org/10.1016/j.ygyno.2020.05.070